Strategic acquisition expands MIRA's pipeline with SKNY-1, a next-generation oral therapeutic targeting the two leading causes of preventable death-obesity and smoking. Under the terms of the LOI ...

today announced that it has signed a non-binding letter of intent (“LOI”) to acquire 100% of a privately held British fuel distribution company (the “Target”). In the proposed acquisition ...

SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent (“LOI”) with Global Digital ...

("Cango" or the "Company") today announced that its Board of Directors (the "Board") recently received a preliminary non-binding letter of intent (the "Letter of Intent") from Enduring Wealth ...

Vincerx Pharma, Inc. announced a non-binding letter of intent to merge with Global Digital Holdings Inc., operating as QumulusAI, a high-performance computing company focused on AI. The merger ...